Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response.

Adams A. et al, (2022), Gut

Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic.

McGregor CG. et al, (2021), Gut, 70, 2398 - 2400

Analysis of systemic epigenetic alterations in inflammatory bowel disease: defining geographical, genetic, and immune-inflammatory influences on the circulating methylome

Kalla R. et al, (2021)

Discovery of a simple two-gene expression biomarker in whole blood predictive of the need for treatment escalation in inflammatory bowel disease

Nowak J. et al, (2021)

Optimising Early Management of Acute Severe Ulcerative Colitis in the Biologics Era: Admission Model for Intensification of Therapy in Acute Severe Colitis (ADMIT–ASC)

Adams A. et al, (2021)

Whole Blood Profiling of T-cell-Derived microRNA Allows the Development of Prognostic models in Inflammatory Bowel Disease

Kalla R. et al, (2020), Journal of Crohn's and Colitis, 14, 1724 - 1733

Blood-based DNA methylation in Crohn's disease and severity of intestinal inflammation.

Kalla R. et al, (2019), Translational gastroenterology and hepatology, 4

Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome.

Olbjørn C. et al, (2019), Clinical and experimental gastroenterology, 12, 37 - 49

Purine metabolism controls innate lymphoid cell function and protects against intestinal injury

Crittenden S. et al, (2018), Immunology and Cell Biology, 96, 1049 - 1059

Editorial: the influence of genetic factors in mediating the effects of tobacco smoke in IBD

Adams A. et al, (2018), Alimentary Pharmacology & Therapeutics, 47, 306 - 307

Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease

Ventham NT. et al, (2016), Nature Communications, 7

Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases

Kalla R. et al, (2016), American Journal of Gastroenterology, 111, 1796 - 1805

Two-stage Genome-wide Methylation Profiling in Childhood-onset Crohnʼs Disease Implicates Epigenetic Alterations at the VMP1/MIR21 and HLA Loci

Adams AT. et al, (2014), Inflammatory Bowel Diseases, 20, 1784 - 1793

Include forthcoming?